Format

Send to

Choose Destination
J Vasc Surg. 2018 Dec;68(6S):201S-207S. doi: 10.1016/j.jvs.2018.02.053. Epub 2018 May 24.

Sphingosine-1-phosphate receptor 1 regulates neointimal growth in a humanized model for restenosis.

Author information

1
Clinic and Polyclinic for Vascular Medicine, University Heart Center Hamburg-Eppendorf, Hamburg, Germany; Clinic and Polyclinic for General and Interventional Cardiology, University Heart Center Hamburg-Eppendorf, Hamburg, Germany.
2
Clinic and Polyclinic for Vascular Medicine, University Heart Center Hamburg-Eppendorf, Hamburg, Germany.
3
Clinic and Polyclinic for Cardiovascular Surgery, Transplant and Stem Cell Immunobiology Laboratory, University Heart Center Hamburg-Eppendorf, Hamburg, Germany.
4
Clinic and Polyclinic for Vascular Medicine, University Heart Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: g.daum@uke.de.

Abstract

OBJECTIVE:

The main objective of this study was to define a role of sphingosine-1-phosphate receptor 1 (S1PR1) in the arterial injury response of a human artery. The hypotheses were tested that injury induces an expansion of S1PR1-positive cells and that these cells accumulate toward the lumen because they follow the sphingosine-1-phosphate gradient from arterial wall tissue (low) to plasma (high).

METHODS:

A humanized rat model was used in which denuded human internal mammary artery (IMA) was implanted into the position of the abdominal aorta of immunosuppressed Rowett nude rats. This injury model is characterized by medial as well as intimal hyperplasia, whereby intimal cells are of human origin. At 7, 14, and 28 days after implantation, grafts were harvested and processed for fluorescent immunostaining for S1PR1 and smooth muscle α-actin. Nuclei were stained with 4',6-diamidine-2'-phenylindole dihydrochloride. Using digitally reconstructed, complete cross sections of grafts, intimal and medial areas were measured, whereby the medial area had virtually been divided into an outer (toward adventitia) and inner (toward lumen) layer. The fraction of S1PR1-positive cells was determined in each layer by counting S1PR1-positive and S1PR1-negative cells.

RESULTS:

The fraction of S1PR1-postive cells in naive IMA is 58.9% ± 6.0% (mean ± standard deviation). At day 28 after implantation, 81.6% ± 4.4% of medial cells were scored S1PR1 positive (P < .01). At day 14, the ratio between S1PR1-positive and S1PR1-negative cells was significantly higher in the lumen-oriented inner layer (9.3 ± 2.1 vs 6.0 ± 1.0; P < .01). Cells appearing in the intima at day 7 and day 14 were almost all S1PR1 positive. At day 28, however, about one-third of intimal cells were scored S1PR1 negative.

CONCLUSIONS:

From these data, we conclude that denudation of IMA specifically induces the expansion of S1PR1-positive cells. Based on the nonrandom distribution of S1PR1-positive cells, we consider the possibility that much like lymphocytes, S1PR1-positive smooth muscle cells also use S1PR1 to recognize the sphingosine-1-phosphate gradient from tissue (low) to plasma (high) and so migrate out of the media toward the intima of the injured IMA.

KEYWORDS:

Intimal hyperplasia; Restenosis; S1PR1; Sphingosine-1-phosphate; Vascular smooth muscle

Comment in

PMID:
29804740
DOI:
10.1016/j.jvs.2018.02.053
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center